Subscribe   RSS Contact Us

Kamp Commentary: Pricing Issues Take Center Stage in D.C.

May 23, 2017 — By Coalition for Healthcare Communication Executive Director John Kamp Participants at last week’s Coalition for Healthcare ... read more

Califf Calls for Off-label Promotion Code of Ethics

May 18, 2017 – At this week’s information-packed Coalition for Healthcare Communication’s Rising Leaders Conference, keynote speaker and former FDA ... read more

The Marketing Implications of Tax Reform

By John Kamp, Coalition for Healthcare Communication Executive Director May 11, 2017 – Although no one seems to like the ... read more

Gottlieb Vote Headed to Full Senate

May 1, 2017 – Having cleared the Senate Committee on Health, Education, Labor and Pensions (HELP) with a 14-9 vote ... read more

What Medical Marketers Can Expect from President Trump, Republican-led Congress

April 24, 2017 – There is no doubt that the Trump administration is likely to change health policy, but the ... read more

Kamp: Three Ways Congress Could Suppress DTC or All Medical Marketing

Coalition Commentary by Executive Director John Kamp April 17, 2017 — Agencies, media and clients all need to watch closely ... read more

States Make Moves to Ease, Restrict Medical Communications

March 31, 2017 – With Congress in a seemingly permanent state of gridlock, individual states are taking actions that may ... read more

Previous Next

Coalition and AAAA Publish Joint FDA Social Media Testimony

At the November 12th FDA Public Hearing on “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools,” John Kamp, the Coalition’s Executive Director,  presented testimony on behalf of the Coalition and the American Association of Advertising Agencies. The testimony offers FDA a regulatory pathway to advance the public health by enabling robust marketing by regulated companies and at the same time coordinating effective enforcement against health fraud on the Internet. The Coalition/AAAA presentation was delivered early on the 1st day of the hearing and lay the groundwork for testimony by other industry leaders.

Topics discussed in the slide presentation include:

  • Problems involved with providing accurate healthcare information in social media
  • How social media can be used to better inform the public
  • What is needed to create a new mindset for the role of FDA-regulated information

View the slide presentation

We invite your comments!

User Comments 1

  1. “At the November 12th FDA Public Hearing on Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools, John Kamp, the Coalition’s Executive Director, will present testimony on behalf of the Coalition and the American Association of Advertising Agencies. The testimony offers FDA a regulatory pathway to advance the public health by enabling robust marketing by regulated companies and at the same time coordinating effective enforcement against health fraud on the Internet. The Coalition/AAAA presentation will be delivered early on the 1st day of the hearing and lay the groundwork for testimony by other industry leaders.”
    – absolutely agree to this post! Very good job and keep it up!
    -Bob
    seo services

    gm0nk3y on Jan 18, 2010 @ 3:24PM